Micardis: profile and news

Insurers get between doc, his patients Feb 26, 2006
Then the Cozaar, Micardis, Benicar and Avapro reps all come and tell me the same thing about their ARB product. What to do about it is the question. ... - The Free Lance-Star,

UPDATE 3-Takeda, other Japan drug makers post strong Q3 Jan 31, 2006
Astellas reported a 13 percent surge in its nine-month results, backed by solid sales of hypertension drug Micardis and immunosuppressant Prograf, used by ... - Reuters

Abbott Reports Record Sales, Earnings and Cash Flow in 2005 Jan 25, 2006
As a result, beginning Jan. 1, 2006, Abbott no longer records sales of low-margin BI products (Mobic, Flomax and Micardis), but still earns a commission. ... - MSN Money

Chemical plant in Petersburg plans addition Dec 8, 2005
Telmisartan is the active ingredient in the hypertension drug Micardis. Tipranavir is the active ingredient in the AIDS treatment product Aptivus. ... - Richmond Times Dispatch,

St. Louis firm to test new West Nile treatment Sep 9, 2005
...failure. Patients typically are given Micardis, which is manufactured by Boehringer Ingelheim, or Atacand, manufactured by AstraZeneca. ... - World Peace Herald,

Genomed looks to tackle West Nile virus 08 Sep 2005
...failure. Patients typically are given Micardis, which is manufactured by Boehringer Ingelheim, or Atacand, manufactured by AstraZeneca. ... - Monsters and Critics.com,

Preliminary Studies Suggest Potential Metabolic Effects of ... Sep 7, 2005
STOCKHOLM, Sweden, September 6, 2005 - Preclinical studies show that the blood pressure lowering medicine, Micardis® (telmisartan), has a beneficial effect on ... - PharmaLive.com (press release),

Potential metabolic effects of telmisartan in preliminary studies Sep 7, 2005
Boehringer Ingelheim markets telmisartan under the trademark Micardis® in 84 countries around the world, including the USA, Japan and major European countries ... - RxPG NEWS,

Long-acting hypertension drugs are best Aug 17, 2005
800 people with high blood pressure who were randomly assigned to take the longer-acting angiotensin receptor blocker telmisartan (brand name Micardis) or the ... - Macleans,

Tokyo shares close at 15-month high Aug 4, 2005
...profit on Tuesday. Astellas said sales had been strong for drugs such as Micardis, the blood pressure product. Suzuki, the auto ... - Financial Times

Asia midday: Japan closes in on 12,000 Aug 2, 2005
...maker Astellas leapt after it posted a 13% rise in quarterly profit, helped by strong demand for high-margin medicines such as the blood-pressure drug Micardis ... - ShareCast

Abbott to stop distributing painkiller Mobic Aug 2, 2005
Beginning Jan. 1, 2006, Abbott will stop distributing Mobic, Flomax and Micardis, Lake County-based Abbott said Monday. Flomax is ... - Chicago Sun-Times

Boehringer Ingelheim H1 sales up 22 pct; to outpace pharma mkt ... Aug 1, 2005
SPIRIVA to 412 mln eur from 185 mln in the same quarter last year, as well as by a 50 pct increase in sales of the high blood pressure drug MICARDIS to 365 mln ... - Forbes

Abbott Labs amends US distribution deal for Boehringer Ingelheim ... Aug 2, 2005
Abbott said it will cease booking sales of Boehringer's Mobic, Flomax and Micardis treatments from 2006, when a co-promotion agreement expires. ... - Forbes

Japan Hot Stocks-Astellas, Suzuki Motor Aug 2, 2005
...maker posted a 13 percent rise in quarterly recurring profit on Tuesday, helped by solid sales of high-margin medicines such as the blood-pressure drug Micardis ... - Reuters

Abbott Laboratories: Co-promotion with Boehringer Ingelheim ... Aug 1, 2005
Ingelheim’s distributor and co-promoter in the United States for three products manufactured by Boehringer Ingelheim: Mobic®, Flomax® and Micardis®. ... - PharmaLive.com (press release)

Japan's Nikkei firm after hitting 12,000 Aug 2, 2005
...it posted a 13 percent rise in quarterly recurring profit on Tuesday, helped by solid sales of high-margin medicines such as the blood-pressure drug Micardis. ... - Washington Post

Nippon Boehringer Ingelheim and Astellas Pharma Have Jointly ... Jul 20, 2005
...(Headquarters: Chuo-ku, Tokyo; President and CEO: Toichi Takenaka), which collaboratively co-promote MICARDIS®, an angiotensin II receptor antagonist, are ... - PharmaLive.com (press release)

Astellas Q1 profit rises 13 pct, keeps forecasts Aug 2, 2005
...such as the new urinary incontinence drug Vesicare and immunosuppressant Prograf grow overseas while demand for the blood-pressure drug Micardis was strong in ... - Reuters

ABBOTT LABS: Drugmaker to drop partner's products Aug 2, 2005
The other two drugs covered by the amended agreement with Germany-based Boehringer are Micardis for high blood pressure and Flomax for treating enlarged ... - Chicago Tribune

Financial Results of Astellas for 1Q/FY2005 Aug 2, 2005
While the angiotensin II receptor blocker Micardis, the treatment of functional symptoms associated with benign prostatic hyperplasia Harnal, the candin ... - PharmaLive.com (press release)

Boehringer Ingelheim Shows Continued Growth Aug 1, 2005
Micardis ® , a drug to combat high blood pressure, attained sales of 365 million euros, up more than 50 percent on the previous year. ... - PharmaLive.com (press release)

Japan drug makers to see anaemic Q1 as costs rise Jul 26, 2005
But Astellas' cost-cutting efforts on top of solid sales of cholesterol-lowering drug Lipitor and blood-pressure drug Micardis in Japan and Vesicare bladder ... - Reuters

Water Pills and Night Sweats Jul 19, 2005
Combination drugs include Aldoril, Atacand HCT, Avalide, Benicar HCT, Diovan HCT, Dyazide, Hyzaar, Lotensin HCT, Maxzide, Micardis HCT, Moduretic, Prinzide ... - Saturday Evening Post

New Data Shows Telmisartan (Micardis/Pritor) Provides Effective ... Apr 1, 2005
ESPRIT) study, published today in Clinical Nephrology, show that treatment with the angiotensin receptor blocker (ARB) telmisartan (Micardis®/Pritor®) is ... - PharmaLive.com

Boehringer Ingelheim reports strong 2004 Apr 7, 2005
...place was Mobic (meloxicam) for rheumatoid arthritis which grew 44per cent to €670m, followed by blood pressure treatment Micardis (telmisartan), which rose ... - in-PharmaTechnologist

Boehringer Ingelheim Continues to Outpace the Market - Boosts ... Apr 6, 2005
In second place was Mobic®, a drug for the symptomatic treatment of rheumatoid arthritis (+ 44% to 670 million euros), followed by Micardis® for the ... - PharmaLive.com,